Ngôn ngữ / Language:
Đăng nhập Đăng ký Hội viên
Hoi Tim mach hoc Viet Nam
   
 
 
Tin tức
Tin Hoạt động
Liên kết qua Internet
Tin tiếng Anh
MedScape Cardiology
TheHeart.org
InCirculation.Net
EuroPCR & AsiaPCR
TCTMd Conference
European Society of Cardiology
 
Trang chủ / Liên kết qua Internet  Print     Email
Liên kết qua Internet
Các Hội Tim mạch và Y khoa (6/23/2010)
Liên kết tới các Hội Tim mạch và Y khoa khác trên Internet ... Chi tiết
Tạp chí Tim mạch và Y học Trực tuyến (6/23/2010)
Liên kết tới các Tạp chí Tim mạch và Y học Trực tuyến qua Internet ... Chi tiết

MedScape Cardiology
Light From BRIGHT: More Fuel for Bivalirudin-Heparin Debate (Mon, 15 Sep 2014 17:00:10 EDT)
US cardiologists are finally getting a look at the Chinese BRIGHT trial, heralded as the first three-way randomization of bivalirudin, heparin, and heparin plus a GP IIb/IIIa inhibitor.
Heartwire
Reassuring Data on Use of DAPT and Anticoagulation (Mon, 15 Sep 2014 15:45:21 EDT)
For patients requiring triple therapy in the ISAR-TRIPLE study, the data suggest that stopping clopidogrel after six weeks won't reduce the bleeding risk, but it won't up the risk of ischemic events either.
Heartwire
Why Is Only One PAC Aberrantly Conducted? (Mon, 15 Sep 2014 14:37:33 EDT)
What ECG feature is on display in this tracing?
Medscape Cardiology
Heart Failure Society of America (HFSA) 18th Annual Scientific Meeting (Mon, 15 Sep 2014 10:43:08 EDT)
Read clinically focused news coverage of key developments from HFSA 2014.
theheart.org on Medscape
As Used, Spironolactone Doesn't Cut 30-Day HF Readmissions (Mon, 15 Sep 2014 08:42:48 EDT)
It's probably a reflection of a long-recognized problem, say researchers; patients in clinical practice just aren't a lot like those in clinical trials.
Heartwire
TheHeart.org
Light From BRIGHT: More Fuel for Bivalirudin-Heparin Debate (Mon, 15 Sep 2014 17:00:10 EDT)
US cardiologists are finally getting a look at the Chinese BRIGHT trial, heralded as the first three-way randomization of bivalirudin, heparin, and heparin plus a GP IIb/IIIa inhibitor. ...

For complete story visit theheart.org.
Reassuring Data on Use of DAPT and Anticoagulation (Mon, 15 Sep 2014 15:45:21 EDT)
For patients requiring triple therapy in the ISAR-TRIPLE study, the data suggest that stopping clopidogrel after six weeks won't reduce the bleeding risk, but it won't up the risk of ischemic...

For complete story visit theheart.org.
Why Is Only One PAC Aberrantly Conducted? (Mon, 15 Sep 2014 14:37:33 EDT)
What ECG feature is on display in this tracing? Medscape Cardiology

For complete story visit theheart.org.
Heart Failure Society of America (HFSA) 18th Annual Scientific Meeting (Mon, 15 Sep 2014 10:43:08 EDT)
Read clinically focused news coverage of key developments from HFSA 2014. theheart.org on Medscape

For complete story visit theheart.org.
As Used, Spironolactone Doesn't Cut 30-Day HF Readmissions (Mon, 15 Sep 2014 08:42:48 EDT)
It's probably a reflection of a long-recognized problem, say researchers; patients in clinical practice just aren't a lot like those in clinical trials. Heartwire

For complete story visit theheart.org.